The association of birthweight with maternal and cord serum and amniotic fluid growth hormone and insulin levels, and with neonatal and maternal factors in pregnant women who delivered at term
-
Mehmet A. Osmanağaoğlu
, Selen Osmanağaoğlu und Hasan Bozkaya
Abstract
Aim: To investigate the influence of maternal and cord serum and amniotic fluid growth hormone (GH) and insulin and other neonatal and maternal factors on birthweight.
Methods: A total of 160 pregnant women at 38–42 weeks' gestation were studied. All infants were categorized as small for gestational age (SGA) (n=50), large for gestational age (LGA) (n=50) or average for gestational age (AGA) (n=60). GH and insulin levels were measured in maternal and cord serum and amniotic fluid at birth.
Results: GH levels in maternal and cord serum and amniotic fluid showed no differences among the three weight groups (P>0.05). The cord insulin level was significantly lower in SGA (P<0.01). The insulin level in venous cord blood correlated with birth and placental weights and neonatal height, whereas maternal serum and amniotic fluid insulin levels, and maternal and cord serum and amniotic fluid GH levels did not show any correlation with birthweight. The cord GH level at birth was correlated with GH levels after 4 postnatal weeks in the SGA group (P<0.01). In addition, birthweight showed a correlation with prepartum maternal weight, maternal weight gain, maternal height, neonatal length and placental weight in all three weight groups.
Conclusions: Cord GH, maternal serum and amniotic fluid GH and insulin levels did not correlate with birthweight in all three weight groups. The lack of correlation for GH levels in maternal and cord serum and amniotic fluid suggests that these compartments may be non-communicating separate units.
References
1 Albertsson-Wikland K, M Boguszewski MJ Karlberg: Children born small-for-gestational age: postnatal growth and hormonal status. Horm Res49 (1998) 7Suche in Google Scholar
2 Caufriez A, F Frankenne, G Hennen, G Copinschi: Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies. Am J Physiol265 (1993) 572Suche in Google Scholar
3 Carpenter MW, JA Canick, JW Hogan, C Shellum, M Somers, JA Star: Amniotic fluid insulin at 14–20 weeks' gestation: association with later maternal glucose intolerance and birth macrosomia. Diabetes Care24 (2001) 1259Suche in Google Scholar
4 Chellakooty M, K Vangsgaard, T Larsen, T Scheike, J Falck-Larsen, J Legarth, AM Andersson, KM Main, NE Skakkebaek, A Juul: A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: association between placental GH and fetal growth. J Clin Endocrinol Metab89 (2004) 384Suche in Google Scholar
5 Clark PM, PC Hindmarsh, AW Shiell, CM Law, JW Honour, DJ Barker: Size at birth and adrenocortical function in childhood Clin Endocrinol (Oxf)45 (1996) 721Suche in Google Scholar
6 Curran AJ, SR Peacey, SM Shalet: Is maternal growth hormone essential for a normal pregnancy? Eur J Endocrinol139 (1998) 54Suche in Google Scholar
7 Cutfield WS, PL Hofman, M Vickers, B Breier, WF Blum, EM Robinson: IGFs and binding proteins in short children with intrauterine growth retardation J Clin Endocrinol Metab87 (2002) 235Suche in Google Scholar
8 de Zegher F, M Vanderschueren-Lodeweyckx, B Spitz, Y Faijerson, F Blomberg, A Beckers, G Hennen, F Frankenne: Perinatal growth hormone (GH) physiology: effect of GH-releasing factor on maternal and fetal secretion of pituitary and placental GH J Clin Endocrinol Metab71 (1990) 520Suche in Google Scholar
9 de Zegher F, I Francois, M van Helvoirt, G Van den Berghe: Clinical Review 89: small as fetus and short as child: from endogenous to exogenous growth hormone. J Clin Endocrinol Metab82 (1997) 2021Suche in Google Scholar
10 Delmis J, A Drazancic, M Ivanisevic, E Suchanek: Glucose, insulin, HGH and IGF-I levels in maternal serum, amniotic fluid and umbilical venous serum: a comparison between late normal pregnancy and pregnancies complicated with diabetes and fetal growth retardation. J Perinat Med20 (1992) 47Suche in Google Scholar
11 Evain-Brion D: Hormonal regulation of fetal growth. Horm Res42 (1994) 20710.1159/000184195Suche in Google Scholar
12 Fowden AL: The role of insulin in prenatal growth. J Dev Physiol12 (1989) 173Suche in Google Scholar
13 Gallaher BW, BH Breier, CL Keven, JE Harding, PD Gluckman: Fetal programming of insulin-like growth factor (IGF)-I and IGF-binding protein-3: Evidence for an altered response to undernutrition in late gestation following exposure to periconceptual undernutrition in the sheep. J Endocrinol159 (1998) 501Suche in Google Scholar
14 Geffner ME: The growth without growth hormone syndrome. Endocrinol Metab Clin North Am25 (1996) 64910.1016/S0889-8529(05)70345-5Suche in Google Scholar
15 Gluckman PD, AJ Gunn, A Wray, WS Cutfield, PG Chatelain, O Guilbaud, GR Ambler, P Wilton, K Albertsson-Wikland: Congenital idiopathic growth hormone deficiency associated with prenatal and early postnatal growth failure. The International Board of the Kabi Pharmacia International Growth Study. J Pediatr121 (1992) 920Suche in Google Scholar
16 Gluckman PD: Clinical Review 68: The endocrine regulation of fetal growth in late gestation: the role of insulin-like growth factors. J Clin Endocrinol Metab80 (1995) 104710.1210/jc.80.4.1047Suche in Google Scholar
17 Godfrey, KM, BH Breier, C Cooper: Constraint of the materno-placental supply of nutrients: Causes and consequences. In: O'Brien, PMS, T Wheeler, DJ Barker (eds): Fetal Programming: Influences on Development and Disease in Later Life. RCOG Press, London 1999Suche in Google Scholar
18 Hall K, G Enberg, E Hellem, G Lundin, A Ottosson-Seeberger, V Sara, O Trygstad, U Ofverholm: Somatomedin levels in pregnancy: longitudinal study in healthy subjects and patients with growth hormone deficiency. J Clin Endocrinol Metab59 (1984) 587Suche in Google Scholar
19 Harel Z, GS Tannenbaum: Long-term alterations in growth hormone and insulin secretion after temporary dietary protein restriction in early life in the rat. Pediatr Res38 (1995) 747Suche in Google Scholar
20 Hokken-Koelega AC, MA De Ridder, RJ Lemmen, H Den Hartog, SM De Muinck Keizer-Schrama, SL Drop: Children born small for gestational age: do they catch up? Pediatr Res38 (1995) 267Suche in Google Scholar
21 Ibanez L, N Potau, I Francois, F de Zegher: Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab83 (1998) 3558Suche in Google Scholar
22 Kaplan SL, MM Grumbach, TH Shepard: The ontogenesis of human fetal hormones. I. Growth hormone and insulin. J Clin Invest51 (1972) 3080Suche in Google Scholar
23 Lesage C, J Walker, F Landier, P Chatelain, JL Chaussain, PF Bougneres: Near normalization of adolescent height with growth hormone therapy in very short children without growth hormone deficiency. J Pediatr119 (1991) 29Suche in Google Scholar
24 Liu JP, J Baker, AS Perkins, EJ Robertson, A Efstratiadis: Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell75 (1993) 59Suche in Google Scholar
25 Lubchenco LO, C Hansman, M Dressler, E Boyd: Intrauterine growth and estimated from live born birthweight data. Pediatrics32 (1963) 793Suche in Google Scholar
26 McIntyre HD, R Serek, DI Crane, T Veveris-Lowe, A Parry, S Johnson, KC Leung, KK Ho, M Bougoussa, G Hennen, A Igout, FY Chan, D Cowley, A Cotterill, R Barnard: Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: correlations with fetal growth. J Clin Endocrinol Metab85 (2000) 1143Suche in Google Scholar
27 Spencer GS, GM Robinson, CJ Berry, PM Dobbie: Alteration of maternal growth hormone levels during pregnancy influences both fetal and postnatal growth in rats. Biol Neonate66 (1994) 112Suche in Google Scholar
28 Thomson AM, WZ Billewicz, FE Hytten: The weight of the placenta in relation to birthweight. J Obstet Gynaecol Br Commonw76 (1969) 865Suche in Google Scholar
29 Verhaeghe J, R Van Bree, E Van Herck, J Laureys, R Bouillon, FA Van Assche: C-Peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in umbilical cord serum: correlations with birth weight. Am J Obstet Gynecol169 (1993) 89Suche in Google Scholar
30 von Muhlendahl KE, J Pachaly, M Schmidt-Gollwitzer: Lack of correlation between clinical data and growth hormone concentrations in cord blood. Biol Neonate29 (1976) 281Suche in Google Scholar
31 Wu L, B Liu, S Yu: Correlation of intrauterine growth retardation with endocrine parameters. Zhonghua Fu Chan Ke Za Zhi 35 (2000) 26Suche in Google Scholar
©2005 by Walter de Gruyter Berlin New York
Artikel in diesem Heft
- Declining fertility in the developed world and high maternal mortality in developing countries – how do we respond?
- Maternal obesity and complications during pregnancy
- Cesarean section upon request: is it appropriate for everybody?
- Reply to: Cesarean section upon request: is it appropriate for everybody?
- Characteristics of mothers who delivered the heaviest, average-weight, and lightest triplet sets
- Gestational age-specific distribution of twin birth weight discordance
- The comparison of amino-terminal probrain natriuretic peptide levels in preeclampsia and normotensive pregnancy
- Optimal timing for postprandial glucose measurement in pregnant women with diabetes and a non-diabetic pregnant population evaluated by the Continuous Glucose Monitoring System (CGMS®)
- Structural-tridimensional study of yolk sac in pregnancies complicated by diabetes
- Is cervical dilatation during parturition at term associated with apoptosis?
- Increased soluble VCAM-1 serum levels in preeclampsia are not correlated to urinary excretion or circadian blood pressure rhythm
- The association of birthweight with maternal and cord serum and amniotic fluid growth hormone and insulin levels, and with neonatal and maternal factors in pregnant women who delivered at term
- Amniotic fluid lamellar body counts for the determination of fetal lung maturity: an update
- Comparison of clinical criteria with echocardiographic findings in diagnosing PDA in preterm infants
- Sudden infant death syndrome “gray zone” disclosed only by a study of the brain stem on serial sections
- Incidence and diagnosis of unilateral arterial cerebral infarction in newborn infants
- Non-hydropic intrauterine fetal death more than 5 months after primary parvovirus B19 infection
- A new syndrome of myopathy with muscle spindle excess*
- Causes of left ventricular hypertrabeculation/non-compaction in a neonate and her mother
Artikel in diesem Heft
- Declining fertility in the developed world and high maternal mortality in developing countries – how do we respond?
- Maternal obesity and complications during pregnancy
- Cesarean section upon request: is it appropriate for everybody?
- Reply to: Cesarean section upon request: is it appropriate for everybody?
- Characteristics of mothers who delivered the heaviest, average-weight, and lightest triplet sets
- Gestational age-specific distribution of twin birth weight discordance
- The comparison of amino-terminal probrain natriuretic peptide levels in preeclampsia and normotensive pregnancy
- Optimal timing for postprandial glucose measurement in pregnant women with diabetes and a non-diabetic pregnant population evaluated by the Continuous Glucose Monitoring System (CGMS®)
- Structural-tridimensional study of yolk sac in pregnancies complicated by diabetes
- Is cervical dilatation during parturition at term associated with apoptosis?
- Increased soluble VCAM-1 serum levels in preeclampsia are not correlated to urinary excretion or circadian blood pressure rhythm
- The association of birthweight with maternal and cord serum and amniotic fluid growth hormone and insulin levels, and with neonatal and maternal factors in pregnant women who delivered at term
- Amniotic fluid lamellar body counts for the determination of fetal lung maturity: an update
- Comparison of clinical criteria with echocardiographic findings in diagnosing PDA in preterm infants
- Sudden infant death syndrome “gray zone” disclosed only by a study of the brain stem on serial sections
- Incidence and diagnosis of unilateral arterial cerebral infarction in newborn infants
- Non-hydropic intrauterine fetal death more than 5 months after primary parvovirus B19 infection
- A new syndrome of myopathy with muscle spindle excess*
- Causes of left ventricular hypertrabeculation/non-compaction in a neonate and her mother